233 related articles for article (PubMed ID: 29516917)
21. [Correlation of CXCR4/CXCL12 overexpression to lymph node metastasis and chronic inflammation in cervical adenocarcinoma].
Wei M; Liang LZ; Zhang CQ; Xiong Y; Zhang Y; Shen Y; Li JQ
Ai Zheng; 2007 Mar; 26(3):298-302. PubMed ID: 17355795
[TBL] [Abstract][Full Text] [Related]
22. Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression.
Yasuoka H; Kodama R; Tsujimoto M; Yoshidome K; Akamatsu H; Nakahara M; Inagaki M; Sanke T; Nakamura Y
BMC Cancer; 2009 Jul; 9():220. PubMed ID: 19580679
[TBL] [Abstract][Full Text] [Related]
23. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis.
Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y
Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237
[TBL] [Abstract][Full Text] [Related]
24. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
Zhao S; Wang J; Qin C
J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
[TBL] [Abstract][Full Text] [Related]
25. CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer.
Guembarovski AL; Guembarovski RL; Hirata BKB; Vitiello GAF; Suzuki KM; Enokida MT; Watanabe MAE; Reiche EMV
Mol Biol Rep; 2018 Oct; 45(5):741-750. PubMed ID: 29926386
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast.
Liu F; Lang R; Wei J; Fan Y; Cui L; Gu F; Guo X; Pringle GA; Zhang X; Fu L
Histopathology; 2009 May; 54(6):741-50. PubMed ID: 19438749
[TBL] [Abstract][Full Text] [Related]
27. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment.
Bao S; Darvishi M; H Amin A; Al-Haideri MT; Patra I; Kashikova K; Ahmad I; Alsaikhan F; Al-Qaim ZH; Al-Gazally ME; Kiasari BA; Tavakoli-Far B; Sidikov AA; Mustafa YF; Akhavan-Sigari R
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7945-7968. PubMed ID: 36905421
[TBL] [Abstract][Full Text] [Related]
28. Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha.
Shim H; Lau SK; Devi S; Yoon Y; Cho HT; Liang Z
Biochem Biophys Res Commun; 2006 Jul; 346(1):252-8. PubMed ID: 16756955
[TBL] [Abstract][Full Text] [Related]
29. The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis.
Ying J; Xu Q; Zhang G; Liu B; Zhu L
Med Oncol; 2012 Sep; 29(3):1716-22. PubMed ID: 21630055
[TBL] [Abstract][Full Text] [Related]
30. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.
Phillips RJ; Burdick MD; Lutz M; Belperio JA; Keane MP; Strieter RM
Am J Respir Crit Care Med; 2003 Jun; 167(12):1676-86. PubMed ID: 12626353
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
[TBL] [Abstract][Full Text] [Related]
33. Silencing of CXCR4 blocks progression of ovarian cancer and depresses canonical Wnt signaling pathway.
Wang J; Cai J; Han F; Yang C; Tong Q; Cao T; Wu L; Wang Z
Int J Gynecol Cancer; 2011 Aug; 21(6):981-7. PubMed ID: 21738044
[TBL] [Abstract][Full Text] [Related]
34. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.
Liu X; Xiao Q; Bai X; Yu Z; Sun M; Zhao H; Mi X; Wang E; Yao W; Jin F; Zhao L; Ren J; Wei M
Oncol Rep; 2014 Dec; 32(6):2760-8. PubMed ID: 25310198
[TBL] [Abstract][Full Text] [Related]
35. pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma.
Struckmann K; Mertz K; Steu S; Storz M; Staller P; Krek W; Schraml P; Moch H
J Pathol; 2008 Mar; 214(4):464-71. PubMed ID: 18189328
[TBL] [Abstract][Full Text] [Related]
36. CXCR7/CXCL12 axis is involved in lymph node and liver metastasis of gastric carcinoma.
Xin Q; Zhang N; Yu HB; Zhang Q; Cui YF; Zhang CS; Ma Z; Yang Y; Liu W
World J Gastroenterol; 2017 May; 23(17):3053-3065. PubMed ID: 28533662
[TBL] [Abstract][Full Text] [Related]
37. Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.
Boudot A; Kerdivel G; Habauzit D; Eeckhoute J; Le Dily F; Flouriot G; Samson M; Pakdel F
PLoS One; 2011; 6(6):e20898. PubMed ID: 21695171
[TBL] [Abstract][Full Text] [Related]
38. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma.
Wagner PL; Moo TA; Arora N; Liu YF; Zarnegar R; Scognamiglio T; Fahey TJ
Ann Surg Oncol; 2008 Oct; 15(10):2833-41. PubMed ID: 18696160
[TBL] [Abstract][Full Text] [Related]
39. Leptin promotes bone metastasis of breast cancer by activating the SDF-1/CXCR4 axis.
Duan L; Lu Y; Xie W; Nong L; Jia Y; Tan A; Liu Y
Aging (Albany NY); 2020 Aug; 12(16):16172-16182. PubMed ID: 32836215
[TBL] [Abstract][Full Text] [Related]
40. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
Lin Y; Ma Q; Li L; Wang H
Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
